| | | 62397 | | 29.10.2012 | | Bayer (Schweiz) AG | | | | | | | | | | | | | 11.99. | | | | 11.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Eylea, 2 mg/0,05 ml | Injektionslösung in Durchstechflasche | Injection solution (Afliberceptum 2mg / 0.05ml) | S01LA05 | | | 02 | Eylea 8 mg/0.07 ml | Injektionslösung in Durchstechflasche | Injection solution (Afliberceptum 8mg / 0.07ml) | S01LA05 | |
|
|
